相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of cisplatin-induced acute kidney injury on long-term renal function in patients with solid tumors
Amiko Hino et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2023)
Intraoperative dexmedetomidine use is associated with lower incidence of acute kidney injury after non-cardiac surgery
Yong-Zhong Tang et al.
RENAL FAILURE (2023)
Association of Total Thyroidectomy or Thyroid Lobectomy With the Quality of Life in Patients With Differentiated Thyroid Cancer With Low to Intermediate Risk of Recurrence
Wanna Chen et al.
JAMA SURGERY (2022)
Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
Mototsugu Oya et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2022)
Thyroid Dysfunction and Kidney Dysfunction
Intisar Al Fahdi et al.
Oman Medical Journal (2022)
The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues
Garcilaso Riesco-Eizaguirre et al.
ENDOCRINE-RELATED CANCER (2021)
Long-Term Oncological Outcome Comparison between Intermediate- and High-Dose Radioactive Iodine Ablation in Patients with Differentiated Thyroid Carcinoma: A Propensity Score Matching Study
Kwangsoon Kim et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2021)
Emerging systemic antitarget treatment for differentiated thyroid carcinoma
Neus Baste et al.
CURRENT OPINION IN ONCOLOGY (2021)
Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities
Loredana Lorusso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies
Elisa Stellaria Grassi et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review
Nanno Schreuder et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2021)
Protection from doxorubicin-induced nephrotoxicity by clindamycin: novel antioxidant, anti-inflammatory and anti-apoptotic roles
Kamilia M. Ibrahim et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Elucidating the time-dependent changes in the urinary metabolome under doxorubicin-induced nephrotoxicity
Aiping Li et al.
TOXICOLOGY LETTERS (2020)
Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials
Wei Zhang et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update
Anthony Ciarallo et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Novel Targeted Therapies for Metastatic Thyroid Cancer-A Comprehensive Review
Mohammad Al-Jundi et al.
CANCERS (2020)
Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; Improvement by Acacia hydaspica tannin-rich ethyl acetate fraction
Tayyaba Afsar et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2020)
Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study
Marta Greco et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis
Dmytro Oliinyk et al.
CANCERS (2020)
Improvement of lenvatinib-induced nephrotic syndrome after adaptation to sorafenib in thyroid cancer: A case report
Che Hseuh Yang et al.
WORLD JOURNAL OF CLINICAL CASES (2020)
Iodinated contrast medium: Is there a re(n)al problem? A clinical vignette-based review
Karim Lakhal et al.
CRITICAL CARE (2020)
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paper
Nicola Silvestris et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
ERK1,2 Signalling Pathway along the Nephron and Its Role in Acid-base and Electrolytes Balance
Giovanna Capolongo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors A retrospective study
Hiroyuki Iwasaki et al.
MEDICINE (2019)
Renal toxicity with liposomal doxorubicin in metastatic breast cancer
Kristyn E. Yemm et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
Yoon Young Cho et al.
ENDOCRINE (2019)
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Rehmat Jan et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Current and future immunotherapies for thyroid cancer
Alessandro Antonelli et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Lenvatinib-induced renal failure: two first-time case reports and review of literature
Stefano Cavalieri et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Thyroid surgery for differentiated thyroid cancer - recent advances and future directions
Tracy S. Wang et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Relationship between perioperative thyroid function and acute kidney injury after thyroidectomy
Eun-Young Joo et al.
SCIENTIFIC REPORTS (2018)
Immune cells and inflammation in AKI to CKD progression
Yuki Sato et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals
Alessio Strazzulla et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
How to improve duration and efficiency of the antiproteinuric response to Ramipril: RamiPROT-a prospective cohort study
Paola Cianfrone et al.
JOURNAL OF NEPHROLOGY (2017)
Thyroid dysfunction and kidney disease: An update
Pedro Iglesias et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2017)
Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters
Yoshitaka Saito et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Differentiated Thyroid Cancer-Treatment: State of the Art
Benedikt Schmidbauer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
New Model for Estimating Glomerular Filtration Rate in Patients With Cancer
Tobias Janowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity
Daniel J. Crona et al.
ONCOLOGIST (2017)
Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity
Nicholas S. Andresen et al.
EUROPEAN THYROID JOURNAL (2017)
Evaluation of cystatin C in malignancy and comparability of estimates of GFR in oncology patients
Melissa Jones et al.
PRACTICAL LABORATORY MEDICINE (2017)
Targeted Therapy in Thyroid Cancer: State of the Art
L. Valerio et al.
CLINICAL ONCOLOGY (2017)
Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes
Robert I. Haddad et al.
ENDOCRINE (2017)
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
Martin Schlumberger et al.
CLINICAL CANCER RESEARCH (2016)
Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure
Nami Yeyin et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
The correct renal function evaluation in patients with thyroid dysfunction
Mariadelina Simeoni et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data
Michael J. Sorich et al.
BRITISH JOURNAL OF CANCER (2016)
New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma
Cecile Teuma et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
The interaction between thyroid and kidney disease: an overview of the evidence
Connie M. Rhee
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2016)
Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network
Rimda Wanchoo et al.
CLINICAL KIDNEY JOURNAL (2016)
The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists
Giuseppe Coppolino et al.
JOURNAL OF NEPHROLOGY (2015)
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
Gary L. Francis et al.
THYROID (2015)
BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
Gerald S. Falchook et al.
THYROID (2015)
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Takatoshi Karasawa et al.
TOXICOLOGY LETTERS (2015)
Magnesium protects against cisplatin-induced acute kidney injury without compromising cisplatin-mediated killing of an ovarian tumor xenograft in mice
Malvika H. Solanki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Acute Renal Failure Associated With the New BRAF Inhibitor Vemurafenib
Vincent Launay-Vacher et al.
CANCER (2014)
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network
Marie-Helene Massicotte et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Nephrotic syndrome and acute renal failure during pegylated liposomal doxorubicin treatment
Pierre-Louis Carron et al.
HEMODIALYSIS INTERNATIONAL (2014)
Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer
Linda Shavit et al.
KIDNEY INTERNATIONAL (2014)
Thyroid Disorders and Chronic Kidney Disease
Mohamed Mohamedali et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2014)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells
Alessio Lannetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: First case report and pathophysiological considerations
Helene Francois et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis
JP Holst et al.
THYROID (2005)
Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy
G Karanikas et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Expression of the sodium iodide symporter in human kidney
C Spitzweg et al.
KIDNEY INTERNATIONAL (2001)
分享论文
